SK life science Presents Long-term Data on Cognitive and Psychiatric Adverse Events Associated with XCOPRI® (cenobamate tablets

SK life science Presents Long-term Data on Cognitive and Psychiatric Adverse Events Associated with XCOPRI® (cenobamate tablets) CV in Adults with Partial-Onset (Focal) Seizures at the AAN 2022 Annual Meeting

March 31, 2022

First in-depth, 5-year analysis of cognitive and psychiatric antagonistic occasions related to cenobamate in grownup sufferers with uncontrolled partial-onset (focal) ...

SK life science Presents Long-Term Data of XCOPRI® (cenobamate tablets) CV in Adults with Partial-Onset Seizures at the American Epilepsy Society 2021 Annual Meeting

by admin

December 3, 2021

0

PARAMUS, N.J., Dec. 3, 2021 /PRNewswire/ -- SK Life Science, Inc., a subsidiary of SK Biopharmaceuticals Co., Ltd., an progressive international pharmaceutical ...